T. Rowe Price Associates’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.6M | Buy |
|
|||||
|
2025
Q2 | $39M | Buy |
|
|||||
|
2025
Q1 | $41.9M | Buy |
|
|||||
|
2024
Q4 | $36M | Buy |
|
|||||
|
2024
Q3 | $42M | Buy |
|
|||||
|
2024
Q2 | $23.2M | Buy |
|
|||||
|
2024
Q1 | $403K | Buy |
|
|||||
|
2023
Q4 | $242K | Buy |
|
|||||
|
2023
Q3 | $172K | Buy |
|
|||||
|
2023
Q2 | $155K | Buy |
|
|||||
|
2023
Q1 | $132K | Buy |
|
|||||
|
2022
Q4 | $123K | Buy |
|
|||||
|
2022
Q3 | $71K | Buy |
|
|||||
|
2022
Q2 | $35K | Buy |
|